Michael S. Hadley

1.8k total citations
55 papers, 1.0k citations indexed

About

Michael S. Hadley is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael S. Hadley has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 29 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael S. Hadley's work include Receptor Mechanisms and Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (7 papers) and Asymmetric Synthesis and Catalysis (7 papers). Michael S. Hadley is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (7 papers) and Asymmetric Synthesis and Catalysis (7 papers). Michael S. Hadley collaborates with scholars based in United Kingdom and United States. Michael S. Hadley's co-authors include Graham J. Riley, Geoffrey Stemp, Michael Clark, Barry S. Orlek, John Evans, Frank D. King, Frank Brown, Paul Wyman, Nigel Austin and Wai N. Chan and has published in prestigious journals such as Journal of Medicinal Chemistry, Psychopharmacology and Tetrahedron Letters.

In The Last Decade

Michael S. Hadley

52 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Hadley United Kingdom 16 494 472 277 118 112 55 1.0k
Emmanuel Pinard Switzerland 20 385 0.8× 545 1.2× 321 1.2× 168 1.4× 136 1.2× 44 1.3k
Henner Knust Switzerland 16 509 1.0× 279 0.6× 206 0.7× 146 1.2× 65 0.6× 25 977
Nigel Austin United Kingdom 14 165 0.3× 329 0.7× 253 0.9× 134 1.1× 104 0.9× 24 727
Frank Brown United Kingdom 15 357 0.7× 399 0.8× 187 0.7× 145 1.2× 140 1.3× 30 1.0k
Curt A. Dvorak United States 19 413 0.8× 536 1.1× 182 0.7× 269 2.3× 273 2.4× 37 1.3k
Michael Bös Switzerland 21 536 1.1× 890 1.9× 858 3.1× 139 1.2× 51 0.5× 43 1.8k
Charles Gluchowski United States 21 351 0.7× 598 1.3× 600 2.2× 50 0.4× 50 0.4× 47 1.4k
Jean-Louis Péglion France 22 418 0.8× 539 1.1× 596 2.2× 85 0.7× 36 0.3× 38 1.4k
Pascal George France 22 569 1.2× 645 1.4× 487 1.8× 144 1.2× 19 0.2× 64 1.5k
Silvio Ofner Switzerland 18 135 0.3× 449 1.0× 425 1.5× 199 1.7× 107 1.0× 28 839

Countries citing papers authored by Michael S. Hadley

Since Specialization
Citations

This map shows the geographic impact of Michael S. Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Hadley more than expected).

Fields of papers citing papers by Michael S. Hadley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Hadley. The network helps show where Michael S. Hadley may publish in the future.

Co-authorship network of co-authors of Michael S. Hadley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Hadley. A scholar is included among the top collaborators of Michael S. Hadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Hadley. Michael S. Hadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadley, Michael S., et al.. (2024). Cardiac Magnetic Resonance for Structural Aortic Valve Stenosis Procedures. Journal of Clinical Medicine. 13(17). 5184–5184. 1 indexed citations
2.
Musikantow, Daniel R., Michael S. Hadley, Kelly Jia, et al.. (2024). PO-06-197 VENTRICULAR TACHYCARDIA ABLATION IN A PATIENT WITH LEFT VENTRICULAR PSEUDOANEURYSM USING PULSED FIELD ABLATION. Heart Rhythm. 21(5). S717–S717.
3.
Bienstock, Solomon, et al.. (2023). ‘Is it the same patient?’ Evidence of significant cardiac amyloid regression. European Heart Journal - Cardiovascular Imaging. 25(5). e153–e153.
4.
Brown, Breann L., Michael S. Hadley, & Rebecca Page. (2008). Heterologous high-level E. coli expression, purification and biophysical characterization of the spine-associated RapGAP (SPAR) PDZ domain. Protein Expression and Purification. 62(1). 9–14. 8 indexed citations
5.
Wyman, Paul, Mervyn Thompson, Paul W. Smith, et al.. (2005). Identification of a potent and selective 5-HT1B receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 15(21). 4708–4712. 2 indexed citations
6.
Austin, Nigel, Michael S. Hadley, John D. Harling, et al.. (2003). The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents. Bioorganic & Medicinal Chemistry Letters. 13(10). 1627–1629. 22 indexed citations
7.
Porter, Roderick A., Wai N. Chan, Steven Coulton, et al.. (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters. 11(14). 1907–1910. 119 indexed citations
8.
Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (2001). Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 11(5). 685–688. 13 indexed citations
9.
Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (2000). Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 10(22). 2553–2555. 15 indexed citations
10.
Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (2000). Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides. Bioorganic & Medicinal Chemistry. 8(8). 2085–2094. 8 indexed citations
11.
Avenell, Kim Y., Izzy Boyfield, Michael S. Hadley, et al.. (1999). Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 9(18). 2715–2720. 14 indexed citations
12.
Chan, Wai N., John Evans, Michael S. Hadley, et al.. (1999). Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorganic & Medicinal Chemistry Letters. 9(2). 285–290. 46 indexed citations
13.
Avenell, Kim Y., Izzy Boyfield, Martyn C. Coldwell, et al.. (1998). Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 8(20). 2859–2864. 6 indexed citations
14.
Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (1998). Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity. Bioorganic & Medicinal Chemistry Letters. 8(20). 2903–2906. 12 indexed citations
15.
Chan, Wai N., John Evans, Michael S. Hadley, et al.. (1996). Synthesis of Novel trans-4-(Substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol Derivatives as Potential Anticonvulsant Agents with a Distinctive Binding Profile. Journal of Medicinal Chemistry. 39(23). 4537–4539. 22 indexed citations
16.
Cassidy, Frederick, et al.. (1992). Synthesis and antihypertensive activity of 3-[(substituted-carbonyl)amino]-2H-1-benzopyrans. Journal of Medicinal Chemistry. 35(9). 1623–1627. 61 indexed citations
17.
Hadley, Michael S., et al.. (1992). Substituted benzamides with conformationally restricted side chains. 4. Hetero-azabicyclo[x.y.0] derivatives as gastric prokinetic agents.. Bioorganic & Medicinal Chemistry Letters. 2(10). 1293–1298. 8 indexed citations
18.
Orlek, Barry S., Frank E. Blaney, Frank Brown, et al.. (1991). Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. Journal of Medicinal Chemistry. 34(9). 2726–2735. 171 indexed citations
19.
Brown, Frank, William Campbell, Michael Clark, et al.. (1988). The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide. Psychopharmacology. 94(3). 350–8. 5 indexed citations
20.
King, Frank D., et al.. (1988). Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists. Journal of Medicinal Chemistry. 31(9). 1708–1712. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Pinard Breakdown of academic impact, for papers by Henner Knust Breakdown of academic impact, for papers by Nigel Austin Breakdown of academic impact, for papers by Frank Brown Breakdown of academic impact, for papers by Curt A. Dvorak Breakdown of academic impact, for papers by Michael Bös Breakdown of academic impact, for papers by Charles Gluchowski Breakdown of academic impact, for papers by Jean-Louis Péglion Breakdown of academic impact, for papers by Pascal George Breakdown of academic impact, for papers by Silvio Ofner
Rankless by CCL
2026